Literature DB >> 2510170

DNA binding site of the growth factor-inducible protein Zif268.

B Christy1, D Nathans.   

Abstract

Zif268, a zinc finger protein whose mRNA is rapidly activated in cells exposed to growth factors or other signaling agents, is thought to play a role in regulating the genetic program induced by extracellular ligands. We report that Zif268 has one of the characteristics of a transcriptional regulator, namely, sequence-specific binding to DNA. Zif268 synthesized in Escherichia coli bound to two sites upstream of the zif268 gene and to sites in the promoter regions of other genes. The nucleotide sequences responsible for binding were defined by DNase I footprinting, by methylation interference experiments, and by use of synthetic oligonucleotides. From these results we derived the following consensus sequence for a Zif268 high-affinity binding site: GCGTGGGGCG.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510170      PMCID: PMC298363          DOI: 10.1073/pnas.86.22.8737

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily.

Authors:  T G Hazel; D Nathans; L F Lau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Genomic response to growth factors.

Authors:  D Nathans; L F Lau; B Christy; S Hartzell; Y Nakabeppu; K Ryder
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1988

3.  Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation.

Authors:  A J Cole; D W Saffen; J M Baraban; P F Worley
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

4.  DNA binding activities of three murine Jun proteins: stimulation by Fos.

Authors:  Y Nakabeppu; K Ryder; D Nathans
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

5.  5' flanking sequence and genomic structure of Egr-1, a murine mitogen inducible zinc finger encoding gene.

Authors:  C H Tsai-Morris; X M Cao; V P Sukhatme
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

6.  A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences.

Authors:  B A Christy; L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  jun-D: a third member of the jun gene family.

Authors:  K Ryder; A Lanahan; E Perez-Albuerne; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

8.  Growth factors and membrane depolarization activate distinct programs of early response gene expression: dissociation of fos and jun induction.

Authors:  D P Bartel; M Sheng; L F Lau; M E Greenberg
Journal:  Genes Dev       Date:  1989-03       Impact factor: 11.361

9.  Induction of proto-oncogene JUN/AP-1 by serum and TPA.

Authors:  W W Lamph; P Wamsley; P Sassone-Corsi; I M Verma
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

10.  The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.

Authors:  M Zerial; L Toschi; R P Ryseck; M Schuermann; R Müller; R Bravo
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  167 in total

1.  Blockade of NGF-induced neurite outgrowth by a dominant-negative inhibitor of the egr family of transcription regulatory factors.

Authors:  Y Levkovitz; K J O'Donovan; J M Baraban
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Brain gene expression during REM sleep depends on prior waking experience.

Authors:  S Ribeiro; V Goyal; C V Mello; C Pavlides
Journal:  Learn Mem       Date:  1999 Sep-Oct       Impact factor: 2.460

3.  A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation.

Authors:  Y Levkovitz; J M Baraban
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

4.  A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex.

Authors:  Yechiel Levkovitz; Jay M Baraban
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

5.  EGR4 displays both a cell- and intracellular-specific localization pattern in the developing murine testis.

Authors:  Cathryn A Hogarth; Debra Mitchell; Christopher Small; Michael Griswold
Journal:  Dev Dyn       Date:  2010-11       Impact factor: 3.780

6.  [Egr-1 transcription factor regulates the growth of glomerular mesangium cells].

Authors:  H D Rupprecht; G Hofer; R B Sterzel; H O Schöcklmann
Journal:  Med Klin (Munich)       Date:  1997-02-15

7.  The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses.

Authors:  Feng Fang; Kohtaro Ooka; Swati Bhattacharyya; Swati Bhattachyya; Jun Wei; Minghua Wu; Pan Du; Simon Lin; Francesco Del Galdo; Carol A Feghali-Bostwick; John Varga
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

8.  Expression properties of recombinant pEgr-P16 plasmid in esophageal squamous cell carcinoma induced by ionizing irradiation.

Authors:  Cong-Mei Wu; Tian-Hua Huang; Qing-Dong Xie; De-Sheng Wu; Xiao-Hu Xu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Involvement of JunD in transcriptional activation of the orphan receptor gene nur77 by nerve growth factor and membrane depolarization in PC12 cells.

Authors:  J K Yoon; L F Lau
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Enthalpic factors override the polyelectrolyte effect in the binding of EGR1 transcription factor to DNA.

Authors:  David C Mikles; Vikas Bhat; Brett J Schuchardt; Caleb B McDonald; Amjad Farooq
Journal:  J Mol Recognit       Date:  2014-02       Impact factor: 2.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.